Advertisement
Singapore markets open in 7 hours 35 minutes

  • Straits Times Index

    3,313.48
    +8.49 (+0.26%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • Dow

    40,003.59
    +134.19 (+0.34%)
     

  • Nasdaq

    16,685.97
    -12.33 (-0.07%)
     

  • Bitcoin USD

    66,754.07
    -210.74 (-0.31%)
     

  • CMC Crypto 200

    1,359.39
    -14.45 (-1.05%)
     

  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     

  • Gold

    2,419.80
    +34.30 (+1.44%)
     

  • Crude Oil

    80.00
    +0.77 (+0.97%)
     

  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     

  • Nikkei

    38,787.38
    -132.92 (-0.34%)
     

  • Hang Seng

    19,553.61
    +177.08 (+0.91%)
     

  • FTSE Bursa Malaysia

    1,616.62
    +5.51 (+0.34%)
     

  • Jakarta Composite Index

    7,317.24
    +70.54 (+0.97%)
     

  • PSE Index

    6,618.69
    -9.51 (-0.14%)
     

Masimo (MASI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Equity Research
·2-min read

Masimo (MASI) reported $492.8 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 12.8%. EPS of $0.77 for the same period compares to $0.87 a year ago.

The reported revenue represents a surprise of +0.95% over the Zacks Consensus Estimate of $488.18 million. With the consensus EPS estimate being $0.71, the EPS surprise was +8.45%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Masimo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Non-healthcare: $153.20 million versus the two-analyst average estimate of $154.33 million.

  • Revenue- Healthcare: $339.60 million versus the two-analyst average estimate of $332.56 million.

  • Gross Profit- Non-healthcare: $44.50 million versus the two-analyst average estimate of $48.35 million.

  • Gross Profit- Healthcare: $211.40 million compared to the $204.92 million average estimate based on two analysts.

View all Key Company Metrics for Masimo here>>>

Shares of Masimo have returned -3.6% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Masimo Corporation (MASI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research